View Item 

Show simple item record

Prospective Head and Neck Cancer Research: A Four‐Decade Bibliometric Perspective
dc.contributor.authorSun, Gordon H.
dc.contributor.authorHoulton, Jeffrey J.
dc.contributor.authorMoloci, Nicholas M.
dc.contributor.authorMacEachern, Mark P.
dc.contributor.authorBradford, Carol R.
dc.contributor.authorPrince, Mark E.
dc.contributor.authorJagsi, Reshma
dc.date.accessioned2017-12-15T16:48:04Z
dc.date.available2017-12-15T16:48:04Z
dc.date.issued2013-05
dc.identifier.citationSun, Gordon H.; Houlton, Jeffrey J.; Moloci, Nicholas M.; MacEachern, Mark P.; Bradford, Carol R.; Prince, Mark E.; Jagsi, Reshma (2013). "Prospective Head and Neck Cancer Research: A Four‐Decade Bibliometric Perspective." The Oncologist 18(5): 584-591.
dc.identifier.issn1083-7159
dc.identifier.issn1549-490X
dc.identifier.urihttps://hdl.handle.net/2027.42/139977
dc.publisherAlphaMed Press
dc.publisherWiley Periodicals, Inc.
dc.subject.otherRadiotherapy
dc.subject.otherFunding
dc.subject.otherSurgery
dc.subject.otherOtolaryngology
dc.subject.otherChemotherapy
dc.subject.otherBibliometrics
dc.titleProspective Head and Neck Cancer Research: A Four‐Decade Bibliometric Perspective
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelHematology and Oncology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.contributor.affiliationumDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA
dc.contributor.affiliationumDepartment of Otolaryngology‐Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, USA;
dc.contributor.affiliationumRobert Wood Johnson Foundation Clinical Scholars, University of Michigan, Ann Arbor, Michigan, USA;
dc.contributor.affiliationotherA. Alfred Taubman Health Sciences Library and
dc.contributor.affiliationotherDepartment of Otolaryngology‐Head and Neck Surgery, University of Cincinnati, Cincinnati, Ohio, USA;
dc.contributor.affiliationotherVA Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, USA;
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/139977/1/onco0584.pdf
dc.identifier.doi10.1634/theoncologist.2012-0415
dc.identifier.sourceThe Oncologist
dc.identifier.citedreferenceR Horton. Surgical research or comic opera: Questions, but few answers. Lancet. 1996; 347: 984 – 985.
dc.identifier.citedreferenceS Marur, AA Forastiere. Head and neck cancer: Changing epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2008; 83: 489 – 501.
dc.identifier.citedreferenceCollins TR Lecturer Warns Against Overuse of CRT: Says Many Early‐Stage Laryngeal Cancer Patients Overtreated. ENT Today Accessed September 25, 2012 Available at http://www.enttoday.org/details/article/1074133/Lecturer_Warns_Against_Overuse_of_CRT_Says_many_early‐stage_laryngeal_cancer_pat.html
dc.identifier.citedreferenceHT Hoffman, K Porter, LH Karnell. Laryngeal cancer in the United States: Changes in demographics, patterns of care, and survival. Laryngoscope. 2006; 116: 1 – 13.
dc.identifier.citedreferenceJS Moyer, GT Wolf, CR Bradford. Current thoughts on the role of chemotherapy and radiation in advanced head and neck cancer. Curr Opin Otolaryngol Head Neck Surg. 2004; 12: 82 – 87.
dc.identifier.citedreferenceJP Shah, LH Karnell, HT Hoffman. Patterns of care for cancer of the larynx in the United States. Arch Otolaryngol Head Neck Surg. 1997; 123: 475 – 483.
dc.identifier.citedreferenceL Kim, T King, M Agulnik. Head and neck cancer: Changing epidemiology and public health implications. Oncology (Williston Park). 2010; 24: 915 – 919, 924.
dc.identifier.citedreferenceT Bodenheimer. Uneasy alliance—Clinical investigators and the pharmaceutical industry. N Engl J Med. 2000; 342: 1539 – 1544.
dc.identifier.citedreferenceER Dorsey, de J Roulet, JP Thompson. Funding of US biomedical research, 2003–2008. JAMA. 2010; 303: 137 – 143.
dc.identifier.citedreferenceR Jagsi, N Sheets, A Jankovic. Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research. Cancer. 2009; 115: 2783 – 2791.
dc.identifier.citedreferenceJJ Tuech, G Moutel, P Pessaux. Disclosure of competing financial interests and role of sponsors in phase III cancer trials. Eur J Cancer. 2005; 41: 2237 – 2240.
dc.identifier.citedreferenceCM Booth, DW Cescon, L Wang. Evolution of the randomized controlled trial in oncology over three decades. J Clin Oncol. 2008; 26: 5458 – 5464.
dc.identifier.citedreferenceJ Peppercorn, E Blood, E Winer. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials. Cancer. 2007; 109: 1239 – 1246.
dc.identifier.citedreferenceSL Rose, MK Krzyzanowska, S Joffe. Relationships between authorship contributions and authors’ industry financial ties among oncology clinical trials. J Clin Oncol. 2010; 28: 1316 – 1321.
dc.identifier.citedreferenceGH Sun, JJ Houlton, MP Maceachern, et al. Influence of study sponsorship on head and neck cancer randomized trial results. Head Neck. 2012, [Epub ahead of print].
dc.identifier.citedreferenceR Sullivan, S Eckhouse, G Lewison. Using bibliometrics to inform cancer research policy and spending. In Monitoring Financial Flows for Health Research 2007. Geneva, Switzerland: Global Forum for Health Research. 2008, 67 – 78.
dc.identifier.citedreferenceAD Purushotham, G Lewison, R Sullivan. The state of research and development in global cancer surgery. Ann Surg. 2012; 255: 427 – 432.
dc.identifier.citedreferenceH Moses 3rd, ER Dorsey, DH Matheson. Financial anatomy of biomedical research. JAMA. 2005; 294: 1333 – 1342.
dc.identifier.citedreferenceKI Bland. Concerning trends and outcomes for National Institutes of Health funding of cancer research. J Surg Oncol. 2007; 95: 161 – 166.
dc.identifier.citedreferenceKM Higgins, JR Wang. State of head and neck surgical oncology research—A review and critical appraisal of landmark studies. Head Neck. 2008; 30: 1636 – 1642.
dc.identifier.citedreferenceSJ Rangel, B Efron, RL Moss. Recent trends in National Institutes of Health funding of surgical research. Ann Surg. 2002; 236: 277 – 286, discussion 286–287.
dc.identifier.citedreferenceA Cambrosio, P Keating, S Mercier. Mapping the emergence and development of translational cancer research. Eur J Cancer. 2006; 42: 3140 – 3148.
dc.identifier.citedreferenceG Lewison, A Purushotham, M Mason. Understanding the impact of public policy on cancer research: A bibliometric approach. Eur J Cancer. 2010; 46: 912 – 919.
dc.identifier.citedreferenceJL Marshall. Philanthropy, advocacy and colon cancer. Clin Colorectal Cancer. 2011; 10: 290.
dc.identifier.citedreferenceCommittee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Institute of Medicine. Medical Devices and the Public’s Health: The FDA 510(k) Clearance Process at 35 Years. Washington, DC: The National Academies Press. 2011.
dc.identifier.citedreferenceGAO‐09‐190. Medical Devices: FDA Should Take Steps to Ensure that High‐Risk Device Types Are Approved Through the Most Stringent Premarket Review Process. Washington, DC: Government Accountability Office. 2009.
dc.identifier.citedreferenceNJ Meropol, KA Schulman. Cost of cancer care: Issues and implications. J Clin Oncol. 2007; 25: 180 – 186.
dc.identifier.citedreferenceM Mann, A Tendulkar, N Birger. National Institutes of Health funding for surgical research. Ann Surg. 2008; 247: 217 – 221.
dc.identifier.citedreferenceR Jagsi, EA Guancial, CC Worobey. The “gender gap” in authorship of academic medical literature—a 35‐year perspective. N Engl J Med. 2006; 355: 281 – 287.
dc.identifier.citedreferenceM Angell, RD Utiger, AJ Wood. Disclosure of authors’ conflicts of interest: A follow‐up. N Engl J Med. 2000; 342: 586 – 587.
dc.identifier.citedreferenceS Krimsky, LS Rothenberg. Conflict of interest policies in science and medical journals: Editorial practices and author disclosures. Sci Eng Ethics. 2001; 7: 205 – 218.
dc.identifier.citedreferenceK Slim. Limits of evidence‐based surgery. World J Surg. 2005; 29: 606 – 609.
dc.identifier.citedreferenceJ Ferlay, HR Shin, F Bray. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127: 2893 – 2917.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
onco0584.pdf
Size:
632.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.